EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC 4.0

Lenvatinib-associated hyaline occlusive glomerular microangiopathy

Amir Daher, Yael Kenig-Kozlovsky, Marina Tchirkov, Gai Milo, Ofer Ben-Itzhak, Suheir Assady iD

Clinical Kidney Journal · 01.04.2026 · 19 (4)

DOI: 10.1093/ckj/sfag099 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Clinical Kidney Journal, online erschienen am 20.03.2026. Verfasst von Amir Daher und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology and Hypertension, Rambam Health Care Campus, Haifa, Israel. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Clinical Research Institute at Rambam, Harvey and Gloria Kaylie Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nephrologists play a key role in managing renal complications related to malignancy and its treatment. Although immunotherapies and oral small-molecule agents have revolutionized cancer care, severe adverse events may limit their use. We report a distinctive glomerular injury pattern associated with lenvatinib, an oral receptor tyrosine kinase inhibitor. Similar histopathologic features have been observed with bevacizumab and antivascular endothelial growth factor receptor 2 (VEGFR2) antibodies. This case includes extended clinical follow-up, kidney biopsy findings, and therapeutic modification, suggesting a possible association between VEGF–VEGFR2 pathway inhibition and reversible nephrotoxicity.

Schlagwörter

Stichwörter der Autor:innen

glomerular diseaseonconephrologyproteinuriathrombotic microangiopathytyrosine kinase inhibitor

Autor:innen und Institutionen

  • Department of Nephrology and Hypertension, Rambam Health Care Campus, Haifa, Israel.
  • The Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
  • Department of Pathology, Rambam Health Care Campus, Haifa, Israel.
  • Clinical Research Institute at Rambam, Rambam Health Care Campus, Haifa, Israel.

ORCID-Profile: Suheir Assady

Förderung

  • Clinical Research Institute at Rambam
  • Harvey and Gloria Kaylie Foundation

Zitieren

APA

Daher, A., Kenig-Kozlovsky, Y., Tchirkov, M., Milo, G., Ben-Itzhak, O., & Assady, S. (2026). Lenvatinib-associated hyaline occlusive glomerular microangiopathy. Clinical Kidney Journal, 19(4). https://doi.org/10.1093/ckj/sfag099

Vancouver

Daher A, Kenig-Kozlovsky Y, Tchirkov M, Milo G, Ben-Itzhak O, Assady S. Lenvatinib-associated hyaline occlusive glomerular microangiopathy. Clinical Kidney Journal. 2026;19(4). doi:10.1093/ckj/sfag099

BibTeX
@article{Daher2026,
  author = {Daher, Amir and Kenig-Kozlovsky, Yael and Tchirkov, Marina and Milo, Gai and Ben-Itzhak, Ofer and Assady, Suheir},
  title = {Lenvatinib-associated hyaline occlusive glomerular microangiopathy},
  journal = {Clinical Kidney Journal},
  year = {2026},
  volume = {19},
  number = {4},
  doi = {10.1093/ckj/sfag099}
}
Kostenlos starten →